Pre-announcement ERA4Helth JTC5 IICS EffecTrial call

Odbor medzinárodnej spolupráce dáva do pozornosti pilotnú výzvu na nadnárodný klinický výskum – Investigator – Initiated Clinical Studies (IICS) európskeho partnerstva ERA4HEALTH s indikatívnym rozpočtom 240.000€ na jeden projekt bez spoluúčasti ústavu SAV.

Informácie k výzve: https://era4health.eu/

20 November, 2024Publication of EffectTrial call
27 November, 2024Webinar Infoday
28 January, 2025Deadline for pre-proposal submission
15 April, 2025Communication of the results of the pre-proposal assessment (invitation for full proposal)
17 June, 2025Deadline for full proposal submission
25 August – 5 September, 2025Rebuttal stage
25 August – 5 September, 2025Interview to assess the study feasibility 
End of October, 2025Communication of the funding decisions to the applicants
January – May 2026Expected project start (subject to national procedures)

The aims of the call are:

– to support randomised, interventional and pragmatic comparative-effectiveness multi-country Investigator-Initiated clinical studies (IICS).

– to encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct comparative-effectiveness multi-country IICS.

Proposals should address:

– pragmatic comparative effectiveness trials, designed as randomised interventional trials.  

– Comparison of the use of currently approved healthcare interventions either to each other or to the current standard of care.

– Healthcare interventions could include but would not be limited to: diagnostic, screening, prevention and treatment interventions. The interventions can be pharmacological as well as non-pharmacological procedures like nutrition and/or lifestyle interventions, surgery, prognosis methods, use of medical devices, eHealth and digital interventions and other health interventions.

Interventions with high public relevance in the fields of these specific certain diseases or conditions (that are of equal importance):

  • Cardiovascular diseases
  • Metabolic disorders
  • Nutrition and lifestyle-related diseases
  • Non-communicable respiratory diseases

KONTAKTNÁ OSOBA

Ing. Katarína Bibová

T:+ 421 2 57510 136

@: bibova@up.upsav.sk